Biogen Inc. - Company & Market Research Reports

Home /
Companies /
Biogen Inc.

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 146
Immune Disorders Drugs 79
Genomics 78
Biopharmaceuticals 76
Drug Discovery 66
Oncology Drugs 51
Biotechnology 49
Pharmaceuticals 43
Musculoskeletal Disorders Drugs 41
Hematological Drugs 39
Biosimilars and Biosuperiors 30
Alzheimer's Disease Drugs 27
Cardiovascular Drugs 26
Clinical Trials 26
Allergy and Immunology 20
Optical Disorders Drugs 19
Infusions and Injectables 19
Infectious Diseases Drugs 18
Respiratory Drugs 18
Mental Disorders Drugs 18
Gastrointestinal Drugs 17
Needles and Syringes 15
E-Healthcare 14
Psoriasis Drugs 14
Pharmaceutical Manufacturing 14
Immunosuppressive Drugs 14
Neurology 13
Healthcare Services 13
Drug Delivery 12
Hematology 12
Endocrine and Metabolic Disorders Drugs 12
Lymphoma Drugs 11
Analgesics 10
Leukemia Drugs 9
Optical 9
Diagnostics 9
Liver and Kidney Disorders Drugs 9
Therapeutic Area 7
Drugs by Therapeutic Area 7
Pulmonary Medicine 7
Company Reports 6
Enzymes 6
Medical Devices 6
Hospital Management 5
Cardiology 5
Oncology 5
Schizophrenia Drugs 5
Proteomics 4
Neurology Devices 4
Vaccines 4
Dermatological Drugs 4
Pharmaceutical Intermediates 3
Generic Drugs 3
Pharmacoeconomics 3
Lung Cancer Drugs 3
Stem Cells 3
Dermatology 3
Mental Health 3
Vitamins and Dietary Supplements 3
Laboratory Equipment 3
Gastroenterology 3
In Vitro Diagnostics 2
Managed Care 2
Diabetes Devices 2
Biomaterials 2
Skin Cancer Drugs 2
Nanomedicine 2
Anxiety Drugs 2
Asthma Drugs 2
Urology and Nephrology 1
Diabetes Drugs 1
Women's Health 1
Fertility Services 1
Breast Cancer Drugs 1
Prostate Cancer Drugs 1
Colon Cancer Drugs 1
Cervical Cancer Drugs 1
Medical Imaging 1
Orthopedic Devices 1
Infectious Disease Testing 1
Computed Tomography 1
Transdermal and Transmucosal Drug Delivery 1
Biomarkers 1
Surgical Procedures 1
Contrast Media 1
Kidney Cancer Drugs 1
Antibiotics 1
Clinical Skills 1
Pediatrics 1
Anatomy 1
Allergy Drugs 1
Sexual and Reproductive Health Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



272 reviews

905 Results (Page 39 of 46)
- Relevance
  Sort by

New Drug Approvals and Their Contract Manufacture - 2024 Edition

 Report
April 2024
87 Pages
Global

From

€4616EUR$4,995USD£3,892GBP

Ischemic Stroke Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
January 2024
110 Pages
Global

From

€3500EUR$4,057USD£3,054GBP

Next Generation Biologics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2023
93 Pages
Global

From

€3500EUR$4,057USD£3,054GBP

Cell and Gene Therapy Market 2022-2026

 Report
September 2022
120 Pages
Global

From

€2311EUR$2,500USD£1,948GBP

Viral Vectors and Plasmid DNA Manufacturing Market (2nd Edition), 2018-2030

 Report
April 2018
449 Pages
Global

From

€3234EUR$3,499USD£2,726GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Rhematoid Arthritis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
August 2024
93 Pages
Global

From

€3500EUR$4,057USD£3,054GBP

Pharmerging Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
102 Pages
Global

From

€3500EUR$4,057USD£3,054GBP

Nuclear Receptor ROR-Gamma Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
July 2024
99 Pages
Global

From

€3500EUR$4,057USD£3,054GBP

Sicca Syndrome Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
September 2024
110 Pages
Global

From

€3500EUR$4,057USD£3,054GBP

Small Fiber Neuropathy - Pipeline Insight, 2025

 Clinical Trials
April 2025
40 Pages
Global

From

€1155EUR$1,250USD£974GBP

Nrf2 Pathway Activators - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1155EUR$1,250USD£974GBP

Alpha V Beta 3/5/6 Integrin Antagonist - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1155EUR$1,250USD£974GBP

Cutaneous Lupus Erythematosus Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

 Report
September 2023
111 Pages
Global

From

€2311EUR$2,500USD£1,948GBP

Gene Therapy Market Report and Forecast 2023-2031

 Report
May 2023
147 Pages
Global

From

€4574EUR$4,949USD£3,856GBP

Pegylated Proteins Market - Growth, Trends, and Forecasts (2023-2028)

 Report
April 2023
115 Pages
Global

From

€4390EUR$4,750USD£3,701GBP

Immunology Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type

 Report
February 2024
100 Pages
Global

From

€3500EUR$4,057USD£3,054GBP

Autoimmune Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
141 Pages
Global

From

€3500EUR$4,057USD£3,054GBP

The Corporate Reputation of Pharma in 2021- The Patient Perspective - Autoimmune Edition - The Views of 293 Patient Groups (138 of these respondent patient groups specialised in arthritis)

 Report
November 2022
57 Pages
Global

€9822EUR$10,999USD£8,000GBP

Healthcare Supply Chain Management Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4150EUR$4,490USD£3,498GBP

Multiple Sclerosis Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

 Report
March 2025
97 Pages
Global

From

€3500EUR$4,057USD£3,054GBP

905 Results (Page 39 of 46)
- 1
- 37
- 38
- 39
- 40
- 41

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.